THE PI3Kδ INHIBITOR ME‐401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL). (12th June 2019) - Zelenetz, A.D.; Jagadeesh, D.; Kenkre, V.P.; Reddy, N.M.; Stathis, A.; Salman, H.S.; Asch, A.S.; Soumerai, J.; Jhangiani, H.S.; Iasonos, A.; Patel, K.; Carter, J.; et al.